Partial Blocks of Rectus Femoris and Soleus With Botulinum Toxin Type A (Xeomin®) to Improve Gait in Hemiparesis
Clinical trial NCT03119948 · UNKNOWN
Trial details
- NCT number
- NCT03119948
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-01
- Primary completion
- 2017-11-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.